N-Formyl leurosine derivatives in a dosage form effective for tr

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424262, C07D51904, A61K 31475

Patent

active

042798167

ABSTRACT:
New leurosine derivatives of the general formula (1), ##STR1## wherein R stands for hydrogen or formyl, or pharmaceutically acceptable acid addition salts thereof were prepared by oxidizing leurosine or an acid addition salt thereof, optionally formylating the thus-obtained product and then separating, and, if desired, converting any of the free bases into its acid addition salt.

REFERENCES:
patent: 3387001 (1968-06-01), Hargrove et al.
"Cancer Chemotherapy Reports," vol. 1, pp. 10-13 (1959).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-Formyl leurosine derivatives in a dosage form effective for tr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-Formyl leurosine derivatives in a dosage form effective for tr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Formyl leurosine derivatives in a dosage form effective for tr will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2432989

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.